Skip to main content
Caplight Logo









UbiVac, Inc.

UbiVac, Inc.

Private
Portland, OregonHealthcare & Life Scienceshttps://www.ubivac.com/

Last Round

Seed Round

Aug 27, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

UbiVac, Inc. is a biotechnology company that develops therapeutic vaccines and immunotherapies to combat cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

cancer vaccineimmuno-oncologytherapeutic vaccineimmunotherapycancer immunotherapyoncology biotechsolid tumor treatmentdrug discoverybiotech licensingdendritic cell vaccineclinical trialsprecision medicinecancer drug developmentcancer research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UbiVac, Inc. Comparables

Compare UbiVac, Inc. with similar companies based on industry and business-model similarity.

UbiVac, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PDC*line Pharma
84%
Corner Therapeutics
82%
EV Therapeutics
81%

UbiVac, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 27, 2026
VC RoundApr 8, 2022
Corporate FundingSep 29, 2015

Key People

Founding team and executive leadership

Bernard A. Fox

Co-Founder President CEO

Founding Team

UbiVac, Inc. Investors

Notable investors and investment history

UbiVac, Inc. investors
InvestorRounds
National Cancer InstituteGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2026

    $80K seed round completed.

  • May 12, 2026

    Monthly visitors grew 450% MoM, reaching 1.7K.

UbiVac, Inc. Filings

Explore SEC and related filing metadata, where available.

UbiVac, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about UbiVac, Inc.'s valuation, stock price, and market status.

Is UbiVac, Inc. a public or private company?

UbiVac, Inc. is a private company.

What is the current stock price of UbiVac, Inc.?

UbiVac, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is UbiVac, Inc. worth (valuation)?

Valuation information for UbiVac, Inc. is not publicly available.

Can I buy UbiVac, Inc. stock?

UbiVac, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was UbiVac, Inc.'s last funding round?

UbiVac, Inc.'s most recent funding round was VC Round on April 8, 2022.

Who are the main investors in UbiVac, Inc.?

Key investors in UbiVac, Inc. include National Cancer Institute.

Will UbiVac, Inc. IPO soon?

No public IPO plans have been announced for UbiVac, Inc..

How can I track UbiVac, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor UbiVac, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPortland, Oregon
Employee Range5
Year Founded2005
Last FundingAug 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?